IE
IHE icon

Israel Englander’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Israel Englander’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.46M Buy
+45,000
New +$4.06M ﹤0.01% 3099

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Israel Englander's IHE Position: Q4 2015 in Review

Israel Englander sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2015, closing a stake of 5,901 shares — an estimated $291K sold.

Israel Englander first reported a position in IHE in Q1 2015 and held it in 3 quarters. The position peaked at $641K in Q1 2015. 103 funds tracked by Wall St. Rank hold IHE as of Q4 2015.

  • Israel Englander reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
  • Israel Englander sold 5,901 iShares US Pharmaceuticals ETF shares in Q4 2015, an estimated $291K.
  • Israel Englander first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and held it in 3 quarters.
  • Israel Englander's iShares US Pharmaceuticals ETF position peaked at $641K in Q1 2015.
  • 103 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2015.

Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.